↓ Skip to main content

Anakinra Pilot – a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants

Overview of attention for article published in Frontiers in immunology, October 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anakinra Pilot – a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants
Published in
Frontiers in immunology, October 2022
DOI 10.3389/fimmu.2022.1022104
Pubmed ID
Authors

Elys A. Green, David Metz, Robert Galinsky, Rebecka Atkinson, Elizbeth M. Skuza, Megan Clark, Alistair J Gunn, Carl M. Kirkpatrick, Rod W. Hunt, Philip J. Berger, Claudia A. Nold-Petry, Marcel F. Nold

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 19%
Student > Bachelor 3 14%
Student > Doctoral Student 2 10%
Librarian 1 5%
Unspecified 1 5%
Other 1 5%
Unknown 9 43%
Readers by discipline Count As %
Medicine and Dentistry 7 33%
Biochemistry, Genetics and Molecular Biology 3 14%
Arts and Humanities 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Unknown 9 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 June 2024.
All research outputs
#8,808,031
of 26,189,645 outputs
Outputs from Frontiers in immunology
#11,077
of 32,866 outputs
Outputs of similar age
#156,328
of 446,105 outputs
Outputs of similar age from Frontiers in immunology
#527
of 1,953 outputs
Altmetric has tracked 26,189,645 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 32,866 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,105 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 1,953 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.